<DOC>
	<DOCNO>NCT00932737</DOCNO>
	<brief_summary>The primary objective pilot study assess effect Hyoscine Butylbromide ( HBB ) 20 mg comparison placebo , use need , measure subject 's assessment intensity abdominal pain associate cramping ( APC ) treatment two episode .</brief_summary>
	<brief_title>( Hyoscine Butylbromide ) Abdominal Pain Associated With Cramping Demand Basis</brief_title>
	<detailed_description />
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<criteria>History recurrent abdominal pain cramping ( APC ) least three month . Recorded least two episode APC least `` moderate '' intensity ( i.e. , 5 010 point scale ) last one hour eDiary runin period . Experiencing daily episode APC Runin period Active gastrointestinal disease past 12 month include malignancy , inflammatory bowel disease , celiac disease complete partial bowel obstruction undergone major gastrointestinal surgery past 12 month ( patient history appendectomy , cholecystectomy , bilateral tubal ligation csection within past 12 month allow study ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>